International Journal of Obstetrics and Gynecology

Objective To analyze the clinical treatment options and effects of obstetric and gynecological vaginitis diseases. Methods In this study, 62 patients with bacterial vaginosis admitted to the Obstetrics and Gynecology Department of our hospital were screened and divided into an observation group and a control group with 31 cases each according to the random number table method. The patients in the control group were treated with metronidazole tablets alone, and the observation group was treated with metronidazole tablets alone. Nifurtel and nystatin vaginal soft capsules were added to compare and analyze the therapeutic effects of the two groups. Results The time it took for the clinical symptoms of the patients in the observation group to improve was significantly shorter than that of the control group. The improvement of inflammatory factor levels in the patients was significantly better than that of the control group. The final total effective rate of treatment was significantly higher than that of the control group, and the recurrence rate after treatment was the same as that of the control group. Compared with the control group, it was significantly lower (P<0.05). Conclusion The use of metronidazole combined with nifurtel and nystatin vaginal soft capsules for the treatment of obstetric and gynecological bacterial vaginosis patients can achieve more ideal therapeutic effects, improve the clinical symptoms of patients as early as possible, and reduce the levels of inflammatory factors in the body. Improve treatment effect and stability.

Obstetrics and gynecology; Vaginitis; Treatment plan; Effect analysis